Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathway
✍ Scribed by Ian Bruce; Mohammed Akhlaq; Graham C. Bloomfield; Emma Budd; Brian Cox; Bernard Cuenoud; Peter Finan; Peter Gedeck; Julia Hatto; Judy F. Hayler; Denise Head; Thomas Keller; Louise Kirman; Catherine Leblanc; Darren Le Grand; Clive McCarthy; Desmond O’Connor; Charles Owen; Mrinalini S. Oza; Gaynor Pilgrim; Nicola E. Press; Lilya Sviridenko; Lewis Whitehead
- Book ID
- 116318738
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 561 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The PI3K‐AKT pathway can mediate diverse biological responses and is crucial for optimal immune responses and lymphocyte development. Deletion of PI3K subunits or AKT leads to blockage of T‐cell development at the TCR‐β checkpoint. Studies with over‐expression of constitutively activate